Azemiglitazone + GLP-1 Lean Muscle Benefit PC Data Presented at EASL

  • Home
  • Team
  • Science
  • News
  • Contact
  • More
    • Home
    • Team
    • Science
    • News
    • Contact
  • Home
  • Team
  • Science
  • News
  • Contact

Targeting Insulin Resistance In Chronic Metabolic Disease

  

Cirius Therapeutics is a clinical-stage pharmaceutical company developing innovative therapies for patients suffering from diseases caused by insulin resistance including Type 2 Diabetes and Obesity. 


Learn More About Our Science

Powered by

  • Home